#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Non-small cell lung cancer metastatic Asthma Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Obliterative bronchiolitis Deafness Crigler-Najjar syndrome Tourette's disorder Retinopathy proliferative Microscopic polyangiitis Narcolepsy B-cell small lymphocytic lymphoma recurrent Thromboangiitis obliterans Marginal zone lymphoma refractory Von Hippel-Lindau disease Castleman's disease Hairy cell leukaemia Allogenic stem cell transplantation Adenocarcinoma gastric More trials…

    Learn about Rare Diseases

    Basal cell naevus syndrome Hereditary neuropathic amyloidosis – Basic Information Mantle cell lymphoma stage IV Thrombotic thrombocytopenic purpura – Basic Information Methylmalonic acidaemia – Trials in Disease Hereditary angioedema with C1 esterase inhibitor deficiency – Treatment Glycogen storage disease type I – Diagnostics Hereditary hypophosphataemic rickets – Diagnostics Nephroblastoma – Life with Disease Osteosarcoma metastatic – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Propylene Glycol CEFTAROLINE FOSAMIL Heparin Sodium Albiglutide Safinamide Perampanel GSKVX000000044501 Ranolazine Neostigmine Methylsulfate Tanimilast Levoleucovorin Hmb-001 Cilastatin BRENSOCATIB Anhydrous Azithromycin Myrrh Haemophilus Influenzae Dacarbazine Afatinib Colestyramine More therapies…

    Learn about Your Condition

    Chondroplasty White matter lesion Primary hyperthyroidism Complex regional pain syndrome Laryngeal cancer stage III Frontotemporal dementia Papilloma viral infection Thalassaemia Myositis Vaginal infection Thyroidectomy Colour blindness Microscopic polyangiitis Laparoscopic surgery Asplenia More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Clinique Pasteur

Clinique Pasteur

45 Avenue De Lombez, Cs 27617, Toulouse, 31076, France

Want to learn more about this study or check if you can participate? Contact us.

  • Study on the Effectiveness of Carboplatin and Paclitaxel in Treating Cervical Cancer with Para-aortic Lymph Node Involvement

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Cervix carcinoma
    • Cervix carcinoma stage III
    • Cervix carcinoma stage IV
    Investigated Drugs:
    • Carboplatin
    • Paclitaxel
    France

  • Study on Spironolactone for Maintaining Sinus Rhythm in Hypertensive Patients with Atrial Fibrillation and Preserved Heart Function

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Atrial fibrillation
    Investigated Drugs:
    • Micronised Spironolactone
    France

  • A Phase III Study of Elafibranor in Adults with Primary Sclerosing Cholangitis to Assess Efficacy and Safety

    Not yet recruiting

    3 1
    Investigated Diseases:
    • Cholangitis sclerosing
    Investigated Drugs:
    • Elafibranor
    Austria Belgium Czechia Denmark Finland France +8

  • Study on Monitoring Anticoagulant Therapy with Rivaroxaban and Warfarin in Patients with Acute Coronary Syndrome and Atrial Fibrillation

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Acute coronary syndrome
    • Atrial fibrillation
    Investigated Drugs:
    • Rivaroxaban
    • Warfarin Sodium
    France

  • Study on Apalutamide with Radiotherapy and Hormone Therapy for High-Risk Prostate Cancer Patients with Rising PSA After Surgery

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Prostate cancer
    Investigated Drugs:
    • Apalutamide
    France

  • Study on Darolutamide with Radiation Therapy for Patients with Intermediate Unfavorable Risk Prostate Cancer

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Prostate cancer
    Investigated Drugs:
    • Darolutamide
    • Degarelix
    • Goserelin Acetate
    France

  • Study on Cefoxitin and Sodium Chloride for Preventing Infections After Colorectal Surgery

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Post procedural infection
    Investigated Drugs:
    • Cefoxitin Sodium
    • Sodium Chloride
    France

  • Study on the Effectiveness and Safety of Lanifibranor for Adults with Non-Cirrhotic Non-Alcoholic Steatohepatitis (NASH) and Liver Fibrosis Stages F2/F3

    Not recruiting

    3 1
    Investigated Drugs:
    • Lanifibranor
    Belgium Bulgaria Czechia France Germany Hungary +5

  • Title: Study of everolimus with hormone therapy in women with high-risk breast cancer (ER-positive, HER2-negative) who are disease-free after initial treatment

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Hormone receptor positive HER2 negative breast cancer
    Investigated Drugs:
    • Everolimus
    • Placebo
    Belgium France

  • Study Comparing Avelumab, Cetuximab, and Radiotherapy with Standard Treatments for Patients with Advanced Head and Neck Squamous Cell Carcinoma

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Squamous cell carcinoma of head and neck
    Investigated Drugs:
    • Avelumab
    • Cetuximab
    • Cisplatin
    France
Previous Page
1 2 3 4 5 6
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!